Food and Drug Administration Commissioner Robert Califf said Tuesday that he has taken a closer look at the FDA food program and concluded that "fundamental questions about the structure, function, funding and leadership need to be addressed." The statement comes as criticism of the agency, spurred by the recent shortage of infant formula, has mounted.
U.S. infant formula makers are revving up production and the door is open to imported formula, so “we should see improvement in a matter of days” from shortages nationwide, FDA commissioner Robert Califf said Thursday on Capitol Hill. Califf also said he would strengthen food safety procedures at the agency, though key lawmakers argued he was not going far enough.
Dr. Robert Califf, who led the FDA during the last year of the Obama administration, would run the agency again if the Senate agrees with President Biden's nomination. The president said Califf "has the experience and expertise to lead the Food and Drug Administration during a critical time in our nation’s fight to put an end to the coronavirus pandemic."
Alaska Sen. Lisa Murkowski says she is willing to stall a Senate vote on the nomination of Robert Califf as FDA commissioner "until he and FDA agree to mandatory labeling requirements for the AquAdvantage salmon," reports the Washington Post.
President Obama selected Robert Califf, a new arrival in FDA's senior ranks, to become the next commissioner of the agency that regulates products that account for 20 percent of consumer spending.